Free Trial
ASX:MYX

Mayne Pharma Group (MYX) Stock Price, News & Analysis

Mayne Pharma Group logo

About Mayne Pharma Group Stock (ASX:MYX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5.47 million shs
Average Volume
N/A
Market Capitalization
A$446.85 million
P/E Ratio
N/A
Dividend Yield
0.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MYX Stock News Headlines

What if your job didn’t matter — and neither did China’s chip ban?
If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume chip exports to China. That news sent their stocks flying. But here’s the truth: By the time the market reacts to big news, most traders are too late.tc pixel
See More Headlines

MYX Stock Analysis - Frequently Asked Questions

Mayne Pharma Group Limited (ASX:MYX) issued its earnings results on Friday, February, 22nd. The company reported $0.02 earnings per share for the quarter. Mayne Pharma Group had a negative net margin of 44.86% and a negative trailing twelve-month return on equity of 34.78%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mayne Pharma Group investors own include Appen (APX), Aurora Cannabis (ACB), Sundance Energy (SNDE), Turquoise Hill Resources (TRQ), Pilbara Minerals (PILBF), Organigram Global (OGI) and Karoon Energy (KAR).

Company Calendar

Last Earnings
2/22/2019
Today
10/13/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
ASX:MYX
CIK
N/A
Fax
N/A
Employees
780
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($2.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
0.51
Net Income
-A$168.62 million
Net Margins
-44.86%
Pretax Margin
N/A
Return on Equity
-34.78%
Return on Assets
-2.33%

Debt

Debt-to-Equity Ratio
8.55
Current Ratio
1.47
Quick Ratio
0.62

Sales & Book Value

Annual Sales
A$388.40 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.20
Book Value
A$5.59 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
85,070,000
Free Float
N/A
Market Cap
A$446.85 million
Optionable
Not Optionable
Beta
1.24
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:MYX) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners